Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. 1996

C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
INSERM U383, Hôpital Necker-Enfants Malades, Université René Descartes Paris V, France.

To investigate cumulative genetic alterations during development and progression of renal cell carcinoma (RCC), we examined DNAs that were isolated from 148 RCCs for allelic imbalance (AI) at four loci on chromosome arm 3p and at 26 loci on chromosome arm 14q by using polymorphic microsatellite markers and densitometric scanning. Because the analysis of solid tumor unbalanced rearrangements remains difficult due to the large proportion of cells that infiltrate from the stroma, we developed a method for the detection and quantification of AI between control and tumor samples by using polymerase chain reaction (PCR) amplification of microsatellite markers. This technique allows detection down to 20% of contaminating cells with good accuracy. We detected AI on 3p and 14q in 57 and 28% of RCC, respectively. A comparison of genetic changes with clinicopathological data showed that, in marked contrast to AI on 3p, AI on 14q was correlated significantly with the stage and grade of the tumors, with 56 and 58% of RCC in Stage IV and Grade 4, respectively, showing AI. Our results suggest that tumor suppressor genes on 3p, including the von Hippel-Lindau gene, may be involved in early steps of carcinogenesis in clear cell carcinoma and that AI on 14q may play an important role in the progression of clear cell and papillary chromophilic cell carcinomas. Loss of heterozygosity (LOH) on 14q may be a new prognostic factor in RCC. Despite the size of the series of tumors and the number of markers used, only rearrangements that involved the whole length of the long arm of chromosome 14 were observed in the present study. The localization of the putative tumor suppressor gene on 14q will require further investigation of RCC with structural rearrangements of 14q.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002883 Chromosomes, Human, Pair 14 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 14
D005260 Female Females
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
April 1999, European journal of cancer (Oxford, England : 1990),
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
August 2000, Cancer research,
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
July 1998, Oncogene,
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
April 2005, Cancer letters,
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
November 2009, Cancer chemotherapy and pharmacology,
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
March 2000, European journal of cancer (Oxford, England : 1990),
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
April 1995, British journal of cancer,
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
January 2004, Sao Paulo medical journal = Revista paulista de medicina,
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
December 1997, Genes, chromosomes & cancer,
C Béroud, and J C Fournet, and C Jeanpierre, and D Droz, and R Bouvier, and D Froger, and Y Chrétien, and J M Maréchal, and J Weissenbach, and C Junien
August 1997, Cancer genetics and cytogenetics,
Copied contents to your clipboard!